These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 37333109)

  • 1. A Study Protocol to Increase Engagement in Evidence Based Hospital and Community Based Care Using a Serious Injection Related Infections (SIRI) Checklist and Enhanced Peer for Hospitalized PWID (ShaPe).
    Baldwin M; Jeziorski M; Parman M; Gagnon K; Nichols MA; Bradford D; Crockett K; Eaton E
    Res Sq; 2023 Jun; ():. PubMed ID: 37333109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harm reduction for the treatment of patients with severe injection-related infections: description of the Jackson SIRI Team.
    Serota DP; Tookes HE; Hervera B; Gayle BM; Roeck CR; Suarez E; Forrest DW; Kolber MA; Bartholomew TS; Rodriguez AE; Doblecki-Lewis S
    Ann Med; 2021 Dec; 53(1):1960-1968. PubMed ID: 34726095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention services.
    Bartholomew TS; Plesons M; Serota DP; Alonso E; Metsch LR; Feaster DJ; Ucha J; Suarez E; Forrest DW; Chueng TA; Ciraldo K; Brooks J; Smith JD; Barocas JA; Tookes HE
    Addict Sci Clin Pract; 2024 Mar; 19(1):21. PubMed ID: 38528570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivering integrated strategies from a mobile unit to address the intertwining epidemics of HIV and addiction in people who inject drugs: the HPTN 094 randomized controlled trial protocol (the INTEGRA Study).
    Goodman-Meza D; Shoptaw S; Hanscom B; Smith LR; Andrew P; Kuo I; Lake JE; Metzger D; Morrison EAB; Cummings M; Fogel JM; Richardson P; Harris J; Heitner J; Stansfield S; El-Bassel N;
    Trials; 2024 Feb; 25(1):124. PubMed ID: 38360750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. M
    Martel-Laferrière V; Feaster DJ; Metsch LR; Schackman BR; Loignon C; Nosyk B; Tookes H; Behrends CN; Arruda N; Adigun O; Goyer ME; Kolber MA; Mary JF; Rodriguez AE; Yanez IG; Pan Y; Khemiri R; Gooden L; Sako A; Bruneau J
    Trials; 2022 Apr; 23(1):341. PubMed ID: 35461260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients With Serious Injection Drug Use-Related Infections who Experience Patient-Directed Discharges on Oral Antibiotics Have High Rates of Antibiotic Adherence but Require Multidisciplinary Outpatient Support for Retention in Care.
    Lewis S; Liang SY; Schwarz ES; Liss DB; Winograd RP; Nolan NS; Durkin MJ; Marks LR
    Open Forum Infect Dis; 2022 Feb; 9(2):ofab633. PubMed ID: 35106316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-Exposure Prophylaxis Barriers, Facilitators and Unmet Need Among Rural People Who Inject Drugs: A Qualitative Examination of Syringe Service Program Client Perspectives.
    Surratt HL; Yeager HJ; Adu A; González EA; Nelson EO; Walker T
    Front Psychiatry; 2022; 13():905314. PubMed ID: 35706473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Project T-SHARP: study protocol for a multi-site randomized controlled trial of tele-harm reduction for people with HIV who inject drugs.
    Tookes HE; Oxner A; Serota DP; Alonso E; Metsch LR; Feaster DJ; Ucha J; Suarez E; Forrest DW; McCollister K; Rodriguez A; Kolber MA; Chueng TA; Zayas S; McCoy B; Sutherland K; Archer C; Bartholomew TS
    Trials; 2023 Feb; 24(1):96. PubMed ID: 36750867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using nominal group technique to identify barriers and facilitators to preventing HIV using combination same-day pre-exposure prophylaxis and medications for opioid use disorder.
    Eger WH; Altice FL; Lee J; Vlahov D; Khati A; Osborne S; Wickersham JA; Bohonnon T; Powell L; Shrestha R
    Harm Reduct J; 2022 Oct; 19(1):120. PubMed ID: 36307817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated Infectious Disease and Substance Use Disorder Care for the Treatment of Injection Drug Use-Associated Infections: A Prospective Cohort Study With Historical Control.
    Serota DP; Rosenbloom L; Hervera B; Seo G; Feaster DJ; Metsch LR; Suarez E; Chueng TA; Hernandez S; Rodriguez AE; Tookes HE; Doblecki-Lewis S; Bartholomew TS
    Open Forum Infect Dis; 2023 Jan; 10(1):ofac688. PubMed ID: 36632415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methamphetamines and Serious Injection-Related Infections: Opioid Use Care Continuum and Opportunities to End Alabama's Drug Crisis.
    Levy S; Bassler J; Gagnon K; Prados M; Jeziorski M; McCleskey B; Crockett K; Li L; Bradford D; Cropsey K; Eaton E
    Open Forum Infect Dis; 2023 Jan; 10(1):ofac708. PubMed ID: 36726543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of an integrated infectious disease and substance use disorder team for injection drug use-associated infections: a qualitative study.
    Hervera B; Seo G; Bartholomew TS; Chueng TA; Suarez E; Forrest DW; Hernandez S; Rodriguez AE; Tookes HE; Doblecki-Lewis S; Serota DP
    Addict Sci Clin Pract; 2023 Feb; 18(1):8. PubMed ID: 36747268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of peer support on testing, linkage to and engagement in HIV care for people who inject drugs in Indonesia: qualitative perspectives from a community-led study.
    Iryawan AR; Stoicescu C; Sjahrial F; Nio K; Dominich A
    Harm Reduct J; 2022 Feb; 19(1):16. PubMed ID: 35148776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study protocol for an efficacy trial of the "PrEP for Health" intervention to increase HIV PrEP use among people who inject drugs.
    Bazzi AR; Bordeu M; Baumgartner K; Sproesser DM; Bositis CM; Krakower DS; Mimiaga MJ; Biello KB
    BMC Public Health; 2023 Mar; 23(1):513. PubMed ID: 36932369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opportunistic treatment of hepatitis C virus infection (OPPORTUNI-C): study protocol for a pragmatic stepped wedge cluster randomized trial of immediate versus outpatient treatment initiation among hospitalized people who inject drugs.
    Midgard H; Finbråten AK; Malme KB; Berg-Pedersen RM; Tanum L; Olsen IC; Bjørnestad R; Dalgard O
    Trials; 2020 Jun; 21(1):524. PubMed ID: 32539853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qualitative inquiry into perceptions of HIV pre-exposure prophylaxis among people who inject drugs living with hepatitis C in Seattle, WA, USA.
    Barry MP; Austin EJ; Bhatraju EP; Glick SN; Stekler JD; Tung EL; Hansen RN; Williams EC; Gojic AJ; Pickering EI; Tsui JI
    Harm Reduct J; 2022 Nov; 19(1):121. PubMed ID: 36320005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syringe service program-based telemedicine linkage to opioid use disorder treatment: protocol for the STAMINA randomized control trial.
    Watson DP; Swartz JA; Robison-Taylor L; Mackesy-Amiti ME; Erwin K; Gastala N; Jimenez AD; Staton MD; Messmer S
    BMC Public Health; 2021 Mar; 21(1):630. PubMed ID: 33789642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study protocol of a randomized controlled trial comparing two linkage models for HIV prevention and treatment in justice-involved persons.
    Springer SA; Nijhawan AE; Knight K; Kuo I; Di Paola A; Schlossberg E; Frank CA; Sanchez M; Pankow J; Proffitt RP; Lehman W; Pulitzer Z; Thompson K; Violette S; Harding KK;
    BMC Infect Dis; 2022 Apr; 22(1):380. PubMed ID: 35428213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of a bundle to improve HIV testing during hospitalization for people who inject drugs.
    D Grussing E; Pickard B; Khalid A; Smyth E; Childs V; Zubiago J; Nunez H; Jung A; Morales Y; Daudelin DH; Wurcel AG
    Implement Res Pract; 2023; 4():26334895231203410. PubMed ID: 37936964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and protocol of the Buprenorphine plus Outpatient Parenteral Antimicrobial Therapy (B-OPAT) study: a randomized clinical trial of integrated outpatient treatment of opioid use disorder and severe, injection-related infections.
    Fanucchi LC; Murphy SM; Surratt H; Kapadia SN; Walsh SL; Grubbs JA; Thornton AC; Nuzzo P; Lofwall MR
    Ther Adv Infect Dis; 2022; 9():20499361221108005. PubMed ID: 35847566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.